Literature DB >> 24068400

Childhood rhabdomyosarcoma. Anatomo-clinical and therapeutic study on 25 cases. Surgical implications.

Smaranda Diaconescu1, M Burlea, Ingrid Miron, S G Aprodu, Doina Mihăilă, Claudia Olaru, L Miron.   

Abstract

UNLABELLED: Rhabdomyosarcomas (RMS) are the most frequent soft tissue sarcomas of childhood. Despite advances in knowledge about biological pathways of tumorigenesis, risk stratification and multimodal treatment, the immediate and long-term prognosis of these lesions in many countries with limited resources is still poor. PATIENTS AND METHODS: Twenty-five histologically confirmed pediatric RMS were recorded during the period of study. Demography, clinical presentation, diagnostic means, pretreatment staging and post-surgical grouping, histological type, therapy and outcome were evaluated.
RESULTS: The mean age was 6.7 years; the group included 12 boys and 13 girls. Twelve lesions were localized in the genitourinary tract, eight in the trunk and extremities, two cases each in head and neck and retroperitoneum and one case in biliary tract. Primary surgical attempt was performed in 15 patients but only in nine of them underwent complete resection (three with free margins) other six cases achieving removal with residual disease. In 10 cases, solely biopsy was possible. Twenty-four patients received chemotherapy but only four cases performed radiation therapy. Overall survival rate was only 36% (nine cases).
CONCLUSIONS: As mean feature children from our series had late presentation with locally extended (bulky and node positive) lesions and unfavorable sites. Improved multimodal management of RMS in recent years will probably lead to better survival curves in an increasing number of cases and an outstanding outcome in children with locally advanced disease.

Entities:  

Mesh:

Year:  2013        PMID: 24068400

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  4 in total

Review 1.  Rhabdomyosarcoma in adults: new perspectives on therapy.

Authors:  Catalina Ruiz-Mesa; John M Goldberg; Alvaro J Coronado Munoz; Sarah N Dumont; Jonathan C Trent
Journal:  Curr Treat Options Oncol       Date:  2015-06

2.  Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.

Authors:  F Nitzki; N Cuvelier; J Dräger; A Schneider; T Braun; H Hahn
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

3.  The novel tubulin polymerization inhibitor MHPT exhibits selective anti-tumor activity against rhabdomyosarcoma in vitro and in vivo.

Authors:  Yan Mu; Yin Liu; Liwen Li; Cong Tian; Hongyu Zhou; Qiu Zhang; Bing Yan
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

4.  Pediatric laparoscopic partial cystectomy for the treatment of benign bladder tumors and urachal cysts.

Authors:  Hongjie Gao; Jiawei Chen; Guowei Li; Xinhai Cui; Fengyin Sun
Journal:  BMC Urol       Date:  2021-09-15       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.